Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a -3.136% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a CCC(C)CCN1C(Nc2ccccc2)=NC[C@@H]1Cc1ccccc1
b O=C1C=C(c2cccc(O)c2)CCC1
c COc1cc(-c2noc(CCC(=O)NC3CCCC3)n2)cc(OC)c1OC
Answer: c. COc1cc(-c2noc(CCC(=O)NC3CCCC3)n2)cc(OC)c1OC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1cc(-c2noc(CCC(=O)NC3CCCC3)n2)cc(OC)c1OC
COc1cc(-c2noc(CCC(=O)NC3CCCC3)n2)cc(OC)c1OC
N-cyclopentyl-3-[3-(3,4,5-trimethoxyphenyl)-1,2,4-oxadiazol-5-yl]propanamide